Partial breast irradiation: Why, how?

By Hannoun-Levi J.M.   Marsiglia H.   Garbay J.R.   Gerard J.P.  

Cancer Radiotherapie, Vol. 7, Iss. 3, 2003-06 ,pp. : 200-209

Elsevier

Access to resources Recommend Favorite

Assessment of HER2 status in breast cancer - why, when and how?

By Dowsett M.   Cooke T.   Ellis I.   Gullick W.J.   Gusterson B.   Mallon E.   Walker R.  

European Journal of Cancer, Vol. 36, Iss. 2, 2000-01 ,pp. : 170-176

Elsevier

Access to resources Recommend Favorite

Why and How Post-Mastectomy Edema should be Quantified in Patients with Breast Cancer

By Galland C.  

Breast Cancer Research and Treatment, Vol. 75, Iss. 1, 2002-09 ,pp. : 87-89

Springer Publishing Company

Access to resources Recommend Favorite

Defining resectability of colorectal liver metastases: how and why?

By Voorthuizen Theo van   van Gulik Thomas M   Punt Cornelis JA  

Colorectal Cancer, Vol. 2, Iss. 1, 2013-02 ,pp. : 61-72

Future Medicine

Access to resources Recommend Favorite

Interferon and Malignant Disease - How Does it Work and Why Doesn't it Always?

By Grandér Dan   Einhorn Stefan  

Acta Oncologica, Vol. 37, Iss. 4, 1998-10 ,pp. : 331-338

Informa Healthcare

Access to resources Recommend Favorite